Surrozen (SRZN) Equity Ratio (2020 - 2026)

Surrozen (SRZN) recorded quarterly Equity Ratio of 2.3 in Q1 2026, down 21.16% quarter-over-quarter from 1.9 in Q4 2025, and down 4763.34% on a YoY basis from 0.05 in Q1 2025.

Surrozen (SRZN) Equity Ratio (2020 - 2026) Analysis & Trends

Surrozen's Equity Ratio history runs 7 years deep, the most recent figure standing at 2.3 for Q1 2026.

  • In Q1 2026, Equity Ratio fell 4763.34% year-over-year to 2.3; the TTM figure through Mar 2026 stood at 2.3 (down 4763.34% YoY), while the FY2025 annual figure was 1.9, down 331.14% from the prior year.
  • Equity Ratio was 2.3 for Q1 2026 at Surrozen, down from 1.9 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.87 in Q1 2022 to a low of 2.3 in Q1 2026.
  • Historically, Equity Ratio has averaged 0.21 across 5 years, with a median of 0.82 in 2024.
  • The sharpest annual moves came in 2022 and 2026: Equity Ratio soared 250.82% in 2022, then slumped 4763.34% in 2026.
  • A 5-year view of Equity Ratio shows it stood at 0.85 in 2022, then declined by 3.12% to 0.82 in 2023, then sank by 153.58% to 0.44 in 2024, then tumbled by 331.14% to 1.9 in 2025, then dropped by 21.16% to 2.3 in 2026.
  • The last three Equity Ratio figures came in at 2.3 (Q1 2026), 1.9 (Q4 2025), and 0.25 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 191.07
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 0.98
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 0.04
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.58
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 0.42
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 0.73
9 Abivax 94.37 Bn 94.37 Bn - 0.79
10 Surrozen 225,877.86 -106.68 Mn - -2.30

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.30
Dec 31, 2025 -1.90
Sep 30, 2025 -0.25
Jun 30, 2025 0.46
Mar 31, 2025 0.05
Dec 31, 2024 -0.44
Sep 30, 2024 0.12
Jun 30, 2024 0.13
Mar 31, 2024 0.82
Dec 31, 2023 0.82
Sep 30, 2023 0.84
Jun 30, 2023 0.86
Mar 31, 2023 0.85
Dec 31, 2022 0.85
Sep 30, 2022 0.85
Jun 30, 2022 0.86
Mar 31, 2022 0.87
Dec 31, 2021 0.80
Sep 30, 2021 0.82
Jun 30, 2021 0.25